LanzaTech Global, Inc. LNZA

Healthcare SIC 2860 - Industrial Organic Chemicals Nasdaq

Founded in 2005 in New Zealand and now headquartered in Skokie, Illinois, LanzaTech is a leading provider of carbon management and advanced conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical inputs for industry. Our mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging robust, scalable biotechnology solutions to maximize the value of domestic resources.

Gas fermentation is the centerpiece of our offering. Our proprietary process utilizes abundant, locally-sourced waste streams using existing infrastructure, turning off-gases into valuable commodities, while supporting the strategic objective of maximizing the productivity of industrial assets. The process is conducted on existing industrial land, making efficient use of available space and water resources, and driving productivity from legacy and new assets alike.

Last close 6.12 2026-09-04
Market cap $80.1M 2026-06-30 share count
52-week range 5.02 - 44.00

Valuation FY2025 figures against the last close

P/S1.4x
P/E
P/FCF
EV/EBITDA
Dividend yield
Diluted EPS-22.27

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Revenue $55.8M$49.6M$62.6M$37.3M
R&D $53.2M$77.0M$68.1M$53.2M
SG&A $47.0M$50.0M$50.4M$26.8M$951.5K
Total operating expenses $135.0M$158.5M$169.0M$112.9M
Operating income -$79.2M-$108.9M-$106.4M-$75.6M-$1.4M
Pre-tax income -$49.0M-$123.5M-$131.2M-$78.3M$46.7K
Income tax $0$0$0$0$0
Net income -$49.0M-$137.7M-$134.1M-$76.4M$46.7K
EPS, basic -22.27-69.71-0.79-12.37
EPS, diluted -22.27-69.71-0.79-12.37
Shares, diluted (wtd. avg.) $2.2M$2.0M$176.0M$9.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents $13.2M$43.5M$76.3M$83.7M$128.7M$0
Inventory $684.0K$2.2M$1.8M$1.1M
Total current assets $39.7M$99.3M$172.7M$123.9M$680.9K
Property, plant and equipment $17.1M$22.3M$22.8M$19.7M
Total assets $100.2M$174.7M$241.6M$176.9M$150.9M
Accounts payable $10.9M$5.3M$4.1M$7.5M$85.5K
Total current liabilities $27.7M$30.4M$27.8M$56.0M$751.4K
Long-term debt $25.1M$50.0M
Total liabilities $90.9M$161.2M$127.2M$124.9M$11.6M
Retained earnings -$1.02B-$969.6M-$831.9M-$456.2M-$10.7M
Total equity -$3.9M$13.4M$114.5M-$428.7M-$354.9M$0

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Operating cash flow -$64.9M-$89.1M-$97.3M-$84.7M-$510.0K
Depreciation and amortisation $4.2M$5.6M$5.5M$4.7M
Stock-based compensation $7.2M$13.2M$15.2M$2.5M
Capital expenditure $1.3M$5.3M$8.6M$10.7M
Investing cash flow $11.2M$28.4M-$57.9M-$10.7M-$150.0M
Financing cash flow $25.6M$30.2M$148.2M$50.5M$150.9M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001539497-26-001238.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $22.03B -5.2%
LYB LyondellBasell Industries N.V. $20.52B -9.7%
WLK WESTLAKE CORP $9.56B -8.0%
NEU NEWMARKET CORP $8.14B 19.9x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.74B 42.7x 3.5%
REX REX AMERICAN RESOURCES Corp $1.38B 16.6x 1.2%
GPRE Green Plains Inc. $1.08B 16.0%
WLKP Westlake Chemical Partners LP $771.2M 2.7%